Siloam Vision
Siloam Vision is a Portland-based medical-device and software company developing AI-assisted retinal imaging and telemedicine systems, primarily to screen premature infants for retinopathy of prematurity (ROP) in hospital NICUs and underserved global markets.
- Company typePrivate
- Founded2010
- HeadquartersLake Oswego, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Siloam Vision does
Siloam Vision is a venture-backed medical-device and software company developing AI-assisted ophthalmic imaging systems focused primarily on retinopathy of prematurity (ROP), the leading cause of childhood blindness. Its integrated product portfolio combines two proprietary hardware platforms — the iCam Scanning Laser Ophthalmoscope (SLO) camera and the iCam-OCT Optical Coherence Tomography system (featuring a 200-degree contact field of view, 145-degree non-contact field of view, 1060nm swept-source laser, and acquisition speeds up to 1,000 frames per second) — with two software platforms: iTelegen, a telemedicine system for managing ROP exam scheduling, automated reminders, and remote image review, and iTelegen+, which layers in two proprietary AI algorithms (iROP-Dx for automated detection of more-than-mild ROP and iROP-Assist for clinician-assistive analysis) that were recognized with the FDA's first Breakthrough Device Designation for AI-based ROP screening.
The company targets two end markets: neonatal intensive care units (NICUs) in hospitals serving premature infants at risk of ROP, and broader ophthalmology practices needing ultra-wide-field retinal imaging across all age groups. Its go-to-market is enterprise field sales to hospitals and healthcare systems, supplemented by a flagship strategic partnership with Orbis International for humanitarian deployment in underserved regions; an active AI-assisted ROP screening program has been running in Mongolia since 2023 and is planned to extend to Bangladesh.
Siloam Vision generates revenue through a mix of hardware sales (iCam, iCam-OCT), software licensing (iTelegen, iTelegen+), and non-dilutive grant funding (NIH, SBIR), with a parallel dilutive SAFE-note funding track. It is a Delaware-incorporated, Portland/Oregon-headquartered private company with 1–10 employees, currently in a pre-commercial / investigational-use phase pending full FDA clearance.
Siloam Vision firmographics
Firmographics- Name
- Siloam Vision
- Legal name
- Siloam Vision Inc.
- Website
- https://siloamvision.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Siloam Vision is a Portland-based medical-device and software company developing AI-assisted retinal imaging and telemedicine systems, primarily to screen premature infants for retinopathy of prematurity (ROP) in hospital NICUs and underserved global markets.
- Ownership category
- akta.pro rank
Siloam Vision industry classification
Industry- Product category
- Ophthalmic Medical Imaging Devices
- NAICS
- Ophthalmic Goods Manufacturing (339115)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)
- akta.pro secondary industry
- Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment) (HLAHAJAM)
Keywords
Where Siloam Vision is headquartered
LocationHeadquarters
- HQ city
- Lake Oswego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Siloam Vision business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- SAFE Securities Offering: Exempt securities offering under Rule 506(c) raising capital through Simple Agreements for Future Equity. Minimum investment of $50,000 from outside investors.
- Medical Device Hardware Sales: Sale of proprietary imaging devices including iCam SLO cameras and iCam-OCT systems to healthcare providers and hospitals.
- Software Platform Licensing: Licensing of iTelegen and iTelegen+ software platforms for ROP management and AI-assisted diagnosis to healthcare institutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | SAFE Investment |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Siloam Vision product offering
Product offeringCore offering
Siloam Vision develops and sells an integrated portfolio of ophthalmic imaging hardware and AI-powered software for vision assessment and therapy. The iTelegen and iTelegen+ software platforms manage retinopathy of prematurity (ROP) screening, while the patented iCam handheld SLO camera and iCam-OCT system capture high-resolution retinal images. Together, these products enable AI-assisted diagnosis and remote image review for hospitals, neonatal care units, and eye care professionals, particularly in underserved regions.
Product overview
Siloam Vision offers an integrated eye care technology portfolio comprising both software platforms and hardware imaging devices. The iTelegen™ software platform serves as the core ROP management system, with iTelegen+™ adding AI-powered diagnostic assistance through iROP-Dx and iROP-Assist algorithms. These software platforms integrate with the iCam™ handheld SLO camera and iCam-OCT™ advanced OCT system, which capture retinal images for analysis. Together, these products form a comprehensive solution for preventing blindness through AI-assisted screening and diagnosis of retinopathy of prematurity and other eye conditions.
Differentiator
Problem solved
Functional benefit
Brands
- iTelegen: Intuitive software designed for collaborative care that streamlines ROP exam management, scheduling, and remote image review.
- iTelegen+
- iCam
- iCam-OCT
Quantifiable outcome
- Results within seconds compared to days previously
- +2 more outcomes
Companies that use Siloam Vision
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles3 records
Siloam Vision technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
Siloam Vision partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship and core.
- Orbis InternationalflagshipStrategic partnership with Orbis International to scale ROP screening solution globally. Joint initiative conducted world's first AI-assisted ROP screening program in Mongolia. Program expanding to Bangladesh with screenings scheduled to begin in Dhaka. Includes training for doctors in remote provinces using smartphone-attached retinal cameras.
- Harvard Medical SchoolcoreResearch collaboration with Harvard Medical School as part of the iROP consortium for imaging and informatics research in retinopathy of prematurity since 2010.
- Oregon Health & Science University (OHSU)coreResearch collaboration with OHSU where founders Dr. Pete Campbell and Dr. Paul Chan are faculty members. OHSU research coverage of company's technology development including FDA breakthrough designation.
Scale indicators5 records
Recent moves5 records
Expansion highlights6 records
Siloam Vision competitors and assessment
Company assessmentOthers
- Orbis International: Orbis International is Siloam Vision's flagship humanitarian distribution partner running the Mongolia and Bangladesh ROP programs — not a competitor, but a closely adjacent ecosystem participant whose priorities materially shape Siloam's go-to-market.
Direct peers
- Phoenix Technology Group: Phoenix Technology Group (now part of Leica Microsystems) makes the RetCam wide-field pediatric retinal imaging system used in NICUs for ROP screening — a direct competitor to Siloam's iCam/iCam-OCT in the same clinical workflow.
- Digital Diagnostics (IDx): Digital Diagnostics commercializes IDx-DR, the first FDA-authorized autonomous AI diagnostic system for diabetic retinopathy — a comparable autonomous AI diagnostic regulatory and commercial pathway to Siloam's iROP-Assist AI.
- Eyenuk: Eyenuk's EyeArt system is an FDA-cleared AI platform for autonomous diabetic retinopathy detection from retinal images, directly comparable to Siloam's iTelegen+/iROP-Assist AI for automated disease screening in eye care.
- AEYE Health: AEYE Health develops FDA-cleared AI for autonomous retinal disease screening from fundus images, including diabetic retinopathy, and is moving into adjacent retinal indications that overlap directly with Siloam's AI-ROP workflow.
Broad incumbents
- Heidelberg Engineering: Heidelberg Engineering manufactures the SPECTRALIS OCT and HRA imaging platforms widely used in retina practices — a broad incumbent with overlapping OCT/SLO capabilities that compete against the iCam-OCT system.
- Optos (Nikon): Optos, owned by Nikon, is the dominant ultra-widefield retinal imaging incumbent (Panoramic 200, California) used in ophthalmology clinics worldwide — a broader commercial incumbent competing with Siloam's iCam SLO ultra-widefield system.
- Carl Zeiss Meditec: Carl Zeiss Meditec offers the CIRRUS HD-OCT and PLEX Elite OCT systems with broad clinical retinal imaging adoption — a large incumbent whose OCT portfolio directly overlaps with Siloam's iCam-OCT positioning.
Emerging players
- iCare (Icare Finland Oy): iCare manufactures handheld ophthalmic diagnostic devices (tonometry, retinal imaging) used in primary care and emerging markets — comparable in form factor and portability philosophy to Siloam's handheld iCam SLO.
- RetinAI Medical: RetinAI builds AI-based image analysis platforms for retinal disease management (Discovery, IOL prediction) — an emerging peer in ophthalmic AI workflow software that overlaps with iTelegen+ platform capabilities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Siloam Vision social profiles
Digital presenceSiloam Vision financial estimates
Financial estimateRevenue estimate
Valuation estimate
Siloam Vision leadership team
Management profileNumber of profiles
Profiles10 records
Siloam Vision funding detail
Funding detailFunding overview
Funding rounds5 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Siloam Vision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Siloam Vision
What does Siloam Vision do?
Siloam Vision develops and sells an integrated portfolio of ophthalmic imaging hardware and AI-powered software for vision assessment and therapy. The iTelegen and iTelegen+ software platforms manage retinopathy of prematurity (ROP) screening, while the patented iCam handheld SLO camera and iCam-OCT system capture high-resolution retinal images. Together, these products enable AI-assisted diagnosis and remote image review for hospitals, neonatal care units, and eye care professionals, particularly in underserved regions.
Is Siloam Vision a public or private company?
Siloam Vision is a private company. It is classified as venture growth investor backed and is currently operating.
When was Siloam Vision founded?
Siloam Vision was founded in 2010. It employs 1 to 10 people.
Where is Siloam Vision based?
Siloam Vision is headquartered in Lake Oswego, United States, in the North America region.
How does Siloam Vision make money?
Three revenue lines are on record. SAFE Securities Offering is the primary driver. The others are medical Device Hardware Sales and software Platform Licensing.
Who are Siloam Vision's main competitors?
Orbis International is listed as an others. Direct peers are Phoenix Technology Group, Digital Diagnostics (IDx), Eyenuk and AEYE Health. Broad incumbents are Heidelberg Engineering, Optos (Nikon) and Carl Zeiss Meditec. Emerging players are iCare (Icare Finland Oy) and RetinAI Medical.
Does Siloam Vision have an API?
No public API is recorded for Siloam Vision.
What industry is Siloam Vision in?
Siloam Vision's product category is Ophthalmic Medical Imaging Devices. Its primary akta.pro industry code is HLAKAKAN, Ocular Imaging & Diagnostic Testing Centers, with a secondary code of HLAHAJAM, Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment). Its NAICS code is 339115 and its SIC code is 3841.